Lifeward (LFWD) Proxy filing summary

Executive summary

• The annual and extraordinary general meeting is scheduled for October 30, 2026, with in-person attendance planned and remote options if needed.

• Shareholders will vote on nine proposals, including director elections, compensation matters, share issuance, and auditor appointment.

• The Board recommends voting “FOR” Proposals 1-8 and “EVERY YEAR” for Proposal 9.

Voting matters and shareholder proposals

• Proposals include re-election of Class III directors, election of an external director, approval of director and CEO compensation, equity compensation, share issuance above Nasdaq exchange cap, renewal of compensation policy, auditor re-appointment, say-on-pay, and frequency of say-on-pay votes.

• Most proposals require an Ordinary Majority; some require a Special Majority under Israeli law.

• Shareholders can submit position statements and proposals for the 2027 AGM, subject to eligibility and deadlines.

Board of directors and corporate governance

• Board currently has eight seats, six occupied; after the meeting, seven directors are expected.

• Board is divided into three classes, with external directors required due to a controlling shareholder.

• Committees include audit, compensation, and nominating/governance, all meeting Nasdaq and Israeli law requirements.

• Board leadership structure separates CEO and Chairman roles; risk oversight is managed at both committee and board levels.

• Code of Ethics and insider trading policies are in place, with annual reviews of director compensation.